| Literature DB >> 32616259 |
Mi Young Yoon1, Yeong Bin Kim2, Jong Su Ha1, Kwang Won Seo3, Eun Bi Noh2, Se Hyun Son2, Young Ju Lee4.
Abstract
Avian pathogenic Escherichia coli (APEC) is a major pathogen in the poultry industry worldwide including Korea. In this study, the phenotypic and genotypic characteristics of 33 fluoroquinolone (FQ)-resistant APEC isolates from broilers were analyzed. All FQ-resistant APEC isolates showed amino acid exchanges at both gyrA and parC and high minimal inhibitory concentrations for FQs. A total of 11 (33.3%) isolates were positive for the plasmid-mediated quinolone resistance (PMQR) genes, qnrA (8 isolates) and qnrS (3 isolates), and showed multidrug resistance. Among the 11 PMQR-positive isolates, 1 and 2 isolates carried blaCTX-1 and blaCTX-15, respectively, as extended-spectrum β-lactamase (ESBL) producers, and the non-ESBL gene, blaTEM-1, was found in 4 isolates. Among 3 aminoglycoside-resistant isolates, aac(3)-II was only detected in 1 isolate. All 8 APEC isolates with resistance to tetracycline carried the tetA gene. Overall, 6 of the 7 trimethoprim-sulfamethoxazole-resistant isolates carried the sul1 or sul2 genes, while only 2 of the 8 chloramphenicol-resistant isolates carried the catA1 gene. Although 9 isolates carried class I integrons, only 4 isolates carried the gene cassettes dfrA12-aadA2 (2 isolates), dfrA17-aadA5 (1 isolate), extX-psp-aadA2 (1 isolate), and dfrA27 (1 isolate). The most common plasmid replicon was FIB (8 isolates, 72.7%), followed by K/B (4 isolates, 36.4%). Antimicrobial resistance monitoring and molecular analysis of APEC should be performed continuously to surveil the transmission between poultry farms.Entities:
Keywords: APEC; antimicrobial-resistant gene; broiler; multidrug resistance; plasmid-mediated quinolone resistance
Year: 2020 PMID: 32616259 PMCID: PMC7597827 DOI: 10.1016/j.psj.2020.03.029
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Primer sequences used for the amplification.
| Primer | Sequence (5′ → 3′) | Size (bp) | Reference |
|---|---|---|---|
| | F: GACCTCGGTTTAGTTCACAGA | 585 | |
| R: CACACGCTGACGCTGACCA | |||
| Quinolone resistance determining region (QRDR) | |||
| | F: AAATCTGCCCGTGTCGTTGGT | 343 | |
| R: GCCATACCTACGGCGATACC | |||
| | F: AAACCTGTTCAGCGCCGCATT | 395 | |
| R: GTGGTGCCGTTAAGCAAA | |||
| Plasmid-mediated quinolone | |||
| | F: TCAGCAAGAGGATTTCTCA | 627 | |
| R: GGCAGCACTATTACTCCCA | |||
| | F: CGACCTGAGCGGCACTGAAT | 515 | |
| R: TGAGCAACGATGCCTGGTAG | |||
| | F: CGAGATCAATTTACGGGGAATA | 582 | |
| R: AACAAGCTGAAGCGCCTG | |||
| | F: ACCTTCACCGCTTGCACATT | 571 | |
| R: CCAGTGCTTCGAGAATCAGT | |||
| | F: CGTGTTGCTGGAGTTCTTC | 403 | |
| R: CTGCAGGTACTGCGTCATG | |||
| β-lactamases | |||
| TEM | F: CATTTCCGTGTCGCCCTTATTC | 800 | |
| R: CGTTCATCCATAGTTGCCTGAC | |||
| SHV | F: CACTCAAGGATGTATTGTG | 885 | |
| R: TTAGCGTTGCCAGTGCTCG | |||
| OXA | F: TTCAAGCCAAAGGCACGATAG | 702 | |
| R: TCCGAGTTGACTGCCGGGTTG | |||
| CTX-M group I | F: GACGATGTCACTGGCTGAGC | 499 | |
| R: AGCCGCCGACGCTAATACA | |||
| CTX-M group II | F: GCGACCTGGTTAACTACAATCC | 351 | |
| R: CGGTAGTATTGCCCTTAAGCC | |||
| CTX-M group III | F: CGCTTTGCCATGTGCAGCACC | 307 | |
| R: GCTCAGTACGATCGAGCC | |||
| CTX-M group IV | F: GCTGGAGAAAAGCAGCGGAG | 474 | |
| R: GTAAGCTGACGCAACGTCTG | |||
| Aminoglycoside-modifying enzymes (AMEs) | |||
| | F: TGACCTTGCGATGCTCTATG | 509 | |
| R: TTAGGCATCACTGCGTGTTC | |||
| | F: TGAAACGCTGACGGAGCCTC | 369 | |
| R: GTCGAACAGGTAGCACTGAG | |||
| | F: GGGCGCGTCATGGAGGAGTT | 740 | |
| R: TATCGCGACCTGAAAGCGGC | |||
| Tetracyclines | |||
| | F: GTAATTCTGAGCACTGTCGC | 956 | |
| R: CTGCCTGGACAACATTGCTT | |||
| | F: CTCAGTATTCCAAGCCTTTG | 414 | |
| R: ACTCCCCTGAGCTTGAGGGG | |||
| | F: CCTCTTGCGGGATATCGTCC | 505 | |
| R: GGTTGAAGGCTCTCAAGGGC | |||
| Sulfonamide | |||
| | F: CTTCGATGAGAGCCGGCGGC | 433 | |
| R: GCAAGGCGGAAACCCGCGCC | |||
| | F: CGGCATCGTCAACATAACC | 722 | |
| R: GTGTGCGGATGAAGTCAG | |||
| Chloramphenicol | |||
| | F: AGTTGCTCAATGTACCTATAACC | 547 | |
| R: TTGTAATTCATTAAGCATTCTGCC | |||
| | F: CCGCCACGGTGTTGTTGTTATC | 698 | |
| R: CACCTTGCCTGCCCATCATTAG | |||
| Integrons and cassettes | |||
| Class 1 integron | F: GCCTTGCTGTTCTTCTACGG | 558 | |
| R: GATGCCTGCTTGTTCTACGG | |||
| Class 1 cassettes | F: GGCATCCAAGCAGCAAG | variable | |
| R: AAGCAGACTTGACCTGA | |||
| Class 2 integron | F: CACGGATATGCGACAAAAAGGT | 788 | |
| R: GTAGCAAACGAGTGACGAAATG | |||
| Class 2 cassettes | F: CGGGATCCCGGACGGCATGCACGATTTGTA | variable | |
| R: GATGCCATCGCAAGTACGAG | |||
Abbreviations: CTX, cefotaxime; OXA, oxacillinase.
Figure 1Antimicrobial resistance spectrum (A) and classes (B) in 33 fluoroquinolone-resistance avian pathogenic E. coli isolates. AMGs, aminoglycosides; BL/BLICs, β-lactam/β-lactamase inhibitor combinations; CARs, carbapenems; CEPs, cephems; FPIs, folate pathway inhibitors; PCNs, penicillins; PHs, phenicols; TETs, tetracyclines.
Amino acid changes within QRDRs and prevalence of PMQR genes in 33 fluoroquinolone-resistant avian pathogenic E. coli isolates.
| O Serotype | PMQR genes | Amino acid change | MIC (μg/mL) | No. of isolates included | |||
|---|---|---|---|---|---|---|---|
| CIP | ENR | Nor | |||||
| O2 | - | S83 L/D87Y | S80 R | 4 | 8 | 8 | 3 |
| O3 | - | S83 L/D87 N | S80I | 8 | 16 | 16 | 1 |
| O3 | - | S83 L/D87 N | S80 R | 4 | 16 | 16 | 1 |
| O3 | - | S83 L/D87 N | S80I | 8 | 32 | 16 | 1 |
| O9 | S83 L/D87 N | S80I | 8 | 32 | 16 | 1 | |
| O9 | S83 L/D87 N | S80I | 16 | 32 | 32 | 1 | |
| O45 | - | S83 L/D87Y | S80I | 16 | 128 | 64 | 1 |
| O45 | - | S83 L/D87 N | S80I/E84 G | 64 | 128 | >512 | 1 |
| O78 | S83 L/D87 N | S80I | 8 | 32 | 16 | 1 | |
| O78 | - | S83 L/D87 N | S80I | 16 | 32 | 64 | 1 |
| O78 | - | S83 L/D87 N | S80I | 8 | 32 | 16 | 1 |
| O78 | - | S83 L/D87 N | S80I/E84 A | 64 | 128 | >512 | 1 |
| O78 | - | S83 L/D87 N | S80I/E84 G | 64 | 128 | >512 | 1 |
| O86 | - | S83 L/D87 N | S80I | 128 | 128 | 256 | 1 |
| O86 | - | S83 L/D87 N | S80I | 64 | 128 | >512 | 1 |
| O88 | S83 L/D87 N | S80I | 8 | 32 | 16 | 1 | |
| O99 | - | S83 L/D87 N | S80I | 8 | 16 | 16 | 1 |
| O104 | - | S83 L/D87Y | S80 R | 8 | 32 | 16 | 1 |
| O111 | - | S83 L/D87 N | S80I | 8 | 32 | 16 | 1 |
| O115 | S83I/D87 E | S80I | 8 | 32 | 16 | 1 | |
| O128 | - | S83 L/D87Y | S80I | 16 | 64 | 64 | 1 |
| O128 | S83 L/D87 N | S80I | 16 | 32 | 128 | 1 | |
| O133 | - | S83 L/D87 N | S80 R | 8 | 16 | 16 | 1 |
| O141 | S83 L/D87 N | S80I | 16 | 32 | 16 | 1 | |
| O148 | - | S83 L/D87 N | S80I | 32 | 64 | 64 | 1 |
| O166 | - | S83 L/D87Y | S80I | 8 | 32 | 16 | 1 |
| Ogp8 | S83 L/D87 N | S80I | 8 | 32 | 16 | 1 | |
| Ogp8 | S83 L | S80I | 16 | 32 | 16 | 1 | |
| ONT | S83 L/D87 N | S80I | 64 | 128 | 256 | 1 | |
| ONT | S83 L/D87 N | S80I | 16 | 32 | 64 | 1 | |
| ONT | - | S83 L/D87 N | S80I | 128 | 128 | >512 | 1 |
Abbreviations: CIP, ciprofloxacin; ENR, enrofloxacin; MIC, minimum inhibitory concentration; NOR, norfloxacin; PMQR, plasmid-mediated quinolone resistance; QRDR, quinolone resistance-determining regions.
Not detected.
O107 or O117.
Untyped.
Phenotypes and genotypes of 11 PMQR-positive avian pathogenic E. coli isolates.
| Strain no. | PMQR genes | Resistance phenotypes | Resistance genes | Integron and gene cassettes | Plasmid replicon type | O Serotype |
|---|---|---|---|---|---|---|
| O88 | ||||||
| CC-32-20 | AM, AMC, CAZ, CF, CL, CZ, FOX, CIP, TE | - | B/O, FIB, K/B, N | O78 | ||
| CC-32-48 | AM, CIP, SXT, TE | Ⅰ (-) | FIB, Y | ONT | ||
| CC-35-27 | AM, CF, CIP, TE | Ⅰ ( | FIB | O9 | ||
| B/O, | Ogp8 | |||||
| - | O9 | |||||
| O115 | ||||||
| FIB, | ONT | |||||
| FIA, FIC, Frep, | O128 | |||||
| FIA, FIC, X | O141 | |||||
| K/B, HI2, W, Y | Ogp8 |
Underline indicate that was found in the transconjugant strains.
Abbreviations: AM, ampicillin; AMC, amoxicillin-clavulanate; C, chloramphenicol; CAZ, ceftazidime; CF, cephalothin; CIP, ciprofloxacin; CL, cephalexin; CTX, cefotaxime; CXM, cefuroxime; CZ, cefazolin; FEP, cefepime; FOX, cefoxitin; GM, gentamicin; SXT, trimethoprim/sulfamethoxazole; TE, tetracycline.
Not detected.
Untyped.
O107 or O117.